-
D-N-Acetylgalactosamine: Protocol and QC Guide
2026-09-19
This guide explains how to prepare, control, and apply D-N-Acetylgalactosamine in glycoprotein and brain heteropolysaccharide workflows. It is suitable for aqueous or DMSO-based procedures, but not for ethanol-dependent methods or long-term storage of prepared solutions.
-
Sodium Phosphate Dibasic Buffering Guide
2026-09-19
Sodium phosphate dibasic, or Na2HPO4, is a water-soluble phosphate salt used to stabilize pH in biochemical and molecular biology workflows. Product specifications support its use as a biological assay buffer component, while aquatic-toxicity evidence cited here concerns sulfamonomethoxine rather than Na2HPO4 itself.
-
Fasudil (HA-1077) HCl: ROCK Workflows
2026-09-18
Build more interpretable motility, proliferation, and apoptosis assays with Fasudil (HA-1077) HCl, a selective ROCK inhibitor designed for pathway-focused experiments. This guide connects practical Rho/ROCK workflow controls with the Hippo-pathway strategy used in recent cataract research.
-
Ivermectin Workflows for Parasitology Research
2026-09-18
Build reproducible parasite assays around Ivermectin with controlled solvent handling, staged exposure, and orthogonal viability and motility readouts. A carefully bounded comparison with Gasdermin C research shows how to separate phenotype from mechanism without implying unsupported oncology activity.
-
Ferrostatin-1: An Iron-Homeostasis Assay Guide
2026-09-17
Ferrostatin-1 (Fer-1) is more than a ferroptosis blocker: it can help distinguish downstream lipid damage from upstream iron-storage defects. This guide applies Fer-1 to assay design using mechanistic insights from a lens epithelial cell study on ferritin degradation, Nrf2, PCBP2, and lysosomal iron handling.
-
Moxidectin Synergy with Polyenes in Oral Candidiasis
2026-09-17
A 2024 study found that Moxidectin potentiates amphotericin B and nystatin against Candida albicans by increasing fungal ergosterol biosynthesis and enhancing polyene–cell interaction. The findings provide a mechanistic basis for combination studies in oral candidiasis, while remaining preclinical and insufficient to establish human dosing or therapeutic use.
-
BRD4770 Workflow for G9a Epigenetic Studies
2026-09-16
BRD4770 is a practical G9a histone methyltransferase inhibitor for connecting H3K9 methylation with senescence, cell death, and cancer-cell growth. This workflow emphasizes formulation controls, time-resolved chromatin readouts, and careful translation from PANC-1 studies to broader cancer models.
-
ALC-0315: Practical LNP Formulation Guide
2026-09-15
This guide explains how to handle ALC-0315, an ionizable amino lipid used in lipid nanoparticle formulations for nucleic acid drug delivery and mRNA research. It focuses on solvent selection, storage, mixing, and quality control, while clarifying that product specifications do not by themselves establish a validated formulation, clinical performance, or suitability for direct aqueous use.
-
Tβ4 Promotes Angiogenesis in Critical Limb Ischemia
2026-09-15
Lv et al. show that thymosin-β4 enhances endothelial viability, migration, and angiogenic behavior in critical limb ischemia models through coordinated Notch and NF-κB pathway activity. By combining Tβ4 overexpression with DAPT and BMS pathway inhibition, the study provides pharmacological evidence for a mechanistic link that can inform vascular regeneration research while highlighting important translational limitations.
-
Alfuzosin HCl in Benign Prostatic Hyperplasia
2026-09-14
The reference review positions alfuzosin hydrochloride as a functionally uroselective α1 adrenoceptor antagonist that improves urinary symptoms and flow while limiting cardiovascular tolerability concerns. Its main translational contribution is the integration of prostate physiology, α1-adrenergic receptor signaling, pharmacokinetics, immediate-release versus extended-release formulations, and patient-centered outcomes.
-
Tranexamic Acid: Designing Better Fibrinolysis Studies
2026-09-14
A mechanism-to-translation guide for using Tranexamic Acid in plasmin assays, clot-stability models, and advanced wound-material research, with practical controls for separating molecular activity from formulation performance.
-
Moxidectin: Mechanism, Evidence, and Research Limits
2026-09-13
Moxidectin is a macrocyclic lactone anthelmintic used for parasitic worm control and supported by preclinical evidence as a polyene potentiator against Candida albicans. The 2024 study links this antifungal synergy to increased fungal ergosterol biosynthesis, but the finding does not establish moxidectin as an approved treatment for candidiasis.
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-12
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability to separate proliferative arrest from actual cell killing in cancer drug assays. This framework improves interpretation of drug responses and supports more rigorous assay design, especially when compounds produce delayed or unequal effects on growth and death.
-
Bufalin and STK33: A Translational Cancer Playbook
2026-09-12
Bufalin is more than a natural-product apoptosis tool: emerging evidence positions this cardiotonic steroid as a target-engaging degrader with potential value in triple-negative breast cancer research. This article connects STK33 biology, molecular glue concepts, experimental validation, and translational decision-making.
-
Scutellaria Flavone 2′-Glucosides: 1995 Study
2026-09-11
The 1995 reference study established the structures of two previously unreported flavone 2′-O-glucosides from Scutellaria baicalensis roots and catalogued seven additional phenolics, including baicalin methyl ester. Its value is primarily chemical and taxonomic: chromatographic isolation combined with UV, NMR, NOESY, and high-resolution mass spectrometry provided a framework for identifying structurally related Scutellaria constituents before modern bioassay workflows.